Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
Sponsor: Stanford University
Listed as NCT01727999, this observational or N/A phase trial focuses on Immune Thrombocytopenia and remains completed. Sponsored by Stanford University, it has been updated 11 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — May 2017 [monthly]
Unknown Status NA
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .